|
|
||
|---|---|---|
| UniProt ID |
O94898 |
|
| Entry Name |
LRIG2_HUMAN |
|
| Protein Name |
Leucine-rich repeats and immunoglobulin-like domains protein 2 |
|
| Primary Gene Name |
LRIG2 |
|
| Organism |
Homo sapiens (Human) |
|
| Molecular Function | ||
| Membrane Location |
Cell membrane |
|
|
|
|---|
| Substrate Name | LRIG2 | |
| Cell Type | glioblastoma cells | |
| Substrate Description | ||
| Substrate Function Category | ||
| Substrate Function Subtype | ||
| Sheddase | BACE1 | |
| Shedding-related Disease | ||
| Short Summary of Papers | Soluble LRIG2 ectodomain is released from glioblastoma cells, which promotes proliferation and inhibits the apoptosis of glioblastoma cells. | |
| Cleavage Information | ||
| PMID | 20041192 25353163 |
|
|
|---|
|
|
||
|---|---|---|
|
|
Start | End |
|
|
41 | 807 |
|
|
808 | 828 |
|
|
||||||||
|---|---|---|---|---|---|---|---|---|
| Database | CutSeq | Mapped Position | Protease | Type | Evidence | PMID | ||
| PAPER | PAAG*AGLC | 39 | UNKNOWN | Mass spectrometry | 33796845    | |||
| ASCENT | AAGA*GLCP | 40 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
| ASCENT | AAGA*GLCP | 40 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
| ASCENT | AAGA*GLCP | 40 | UNKNOWN | subtiligase-based N-terminal sequencing | ||||
| MEROPS | AAGA*GLCP | 40 | unknown peptidase | physiologically relevant | Mass spectroscopy | 26796116    | ||
| PAPER | AAGA*GLCP | 40 | UNKNOWN | Mass spectrometry | 33796845    | |||
| ASCENT | ANAS*LTVL | 689 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||